Search Results
CASSINI: can we prevent thrombosis in cancer patients who are at risk?
Rivaroxaban for thromboprophylaxis in high-risk cancer patients: CASSINI results
Alok Khorana: Rivaroxaban Prevents Cancer-Associated VTE
Cancer-Associated Thrombosis and Antiphospholipid Syndrome: An Update for Clinicians
Prediction and Prevention of Cancer-Associated Thromboembolism (CAT)
VTE Prevention in Cancer Patients - Alok A. Khorana, MD
Alok Khorana, MD: Prophylactic Treatment With Rivaroxaban Reduces Cancer Patients' VTE Risk
VTE Prophylaxis in Patients with Cancer with Dr. Jean Connors
Rivaroxaban in high-risk ambulatory cancer patients receiving systemic therapy
Alok A. Khorana: Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients
Cancer Associated Thrombosis
Clot Classroom: Exploring cancer-associated thrombosis with Saskia Middeldorp, M.D., Ph.D.
